These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3738481)

  • 1. Pulmonary sarcoidosis after ten to twenty years.
    Johnston RN
    Scott Med J; 1986 Apr; 31(2):72-8. PubMed ID: 3738481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality in sarcoidosis. A changing pattern of the causes of death.
    Huang CT; Heurich AE; Sutton AL; Lyons HA
    Eur J Respir Dis; 1981 Aug; 62(4):231-8. PubMed ID: 7308337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis.
    Johns CJ; Zachary JB; Ball WC
    Johns Hopkins Med J; 1974 May; 134(5):271-83. PubMed ID: 4826124
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pulmonary sarcoidosis simulating primary acute interstitial fibrosis at presentation. Clinical, radiologic, functional and bronchoalveolar cytologic study in 3 cases].
    Dugas M; Wallaert B; Bart F; Gosselin B; Tonnel AB; Voisin C
    Rev Mal Respir; 1989; 6(3):243-50. PubMed ID: 2740589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationships between noninvasive explorations in pulmonary sarcoidosis of recent origin, as shown in bronchoalveolar lavage, serum, and pulmonary function tests.
    Valeyre D; Saumon G; Bladier D; Amouroux J; Pré J; Battesti JP; Georges R
    Am Rev Respir Dis; 1982 Jul; 126(1):41-5. PubMed ID: 7091907
    [No Abstract]   [Full Text] [Related]  

  • 6. Pulmonary fibrosis in the course of sarcoidosis.
    Dabrowski A; Decker E; Klimkiewicz H; Radwan L; Rowińska E; Szymańska D; Zych D
    Pol Med J; 1970; 9(6):1399-410. PubMed ID: 5505053
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the TNF-α inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET.
    Milman N; Graudal N; Loft A; Mortensen J; Larsen J; Baslund B
    Clin Respir J; 2012 Oct; 6(4):238-47. PubMed ID: 22128762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exercise testing in pulmonary sarcoidosis.
    Ingram CG; Reid PC; Johnston RN
    Thorax; 1982 Feb; 37(2):129-32. PubMed ID: 7080012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage.
    Viskum K; Vestbo J
    Eur Respir J; 1993 Mar; 6(3):349-53. PubMed ID: 8472824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interrelationship between bronchoalveolar lavage cellular constituents and pulmonary functions in sarcoidosis.
    Sharma SK; Pande JN; Verma K; Guleria JS
    Indian J Chest Dis Allied Sci; 1989; 31(2):77-84. PubMed ID: 2606549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function declines in patients with pulmonary sarcoidosis and increased respiratory epithelial permeability to 99mTc-DTPA.
    Chinet T; Dusser D; Labrune S; Collignon MA; Chrétien J; Huchon GJ
    Am Rev Respir Dis; 1990 Feb; 141(2):445-9. PubMed ID: 2405760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis for sarcoidosis in a defined geographical area.
    Huhti E; Poukkula A; Lilja M
    Br J Dis Chest; 1987 Oct; 81(4):381-90. PubMed ID: 3449122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis complicated with major pulmonary artery obstruction and stenosis.
    Hasegawa K; Ohno S; Takada M; Ogino H; Shiotsu S; Takumi C; Hiraoka N; Handa T; Nagai S
    Intern Med; 2012; 51(19):2775-80. PubMed ID: 23037473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional evaluation in stage I pulmonary sarcoidosis.
    Scano G; Monechi GC; Stendardi L; Lo Conte C; Van Meerhaeghe A; Sergysels R
    Respiration; 1986; 49(3):195-203. PubMed ID: 3961283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary sarcoidosis: assessment of disease activity by lung lymphocyte subpopulations.
    Costabel U; Bross KJ; Matthys H
    Klin Wochenschr; 1983 Apr; 61(7):349-56. PubMed ID: 6223178
    [No Abstract]   [Full Text] [Related]  

  • 16. Airway function in chronic pulmonary sarcoidosis with fibrosis.
    Miller A; Teirstein AS; Jackler I; Chuang M; Siltzbach LE
    Am Rev Respir Dis; 1974 Feb; 109(2):179-89. PubMed ID: 4811774
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinicobiologic profile of sarcoidosis. Analysis of 35 cases].
    Lorente JA; Peña JM; Barbado FJ; Serrano JA; Fonseca E; García-Alegría J; Gil A; Vázquez JJ
    Rev Clin Esp; 1985 Feb; 176(3):112-7. PubMed ID: 3991955
    [No Abstract]   [Full Text] [Related]  

  • 18. The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.
    Eule H; Weinecke A; Roth I; Wuthe H
    Ann N Y Acad Sci; 1986; 465():695-701. PubMed ID: 3524366
    [No Abstract]   [Full Text] [Related]  

  • 19. Respiratory function in recent pulmonary sarcoidosis with special reference to small airways.
    Lamberto C; Saumon G; Loiseau P; Battesti JP; Georges R
    Bull Eur Physiopathol Respir; 1985; 21(4):309-15. PubMed ID: 4041656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indices of inflammatory cell activity and pulmonary function in different stages of sarcoidosis.
    Schmekel B; Hällgren R; Stålenheim G; Venge P
    Acta Med Scand; 1982; 211(5):393-9. PubMed ID: 7051763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.